In particular, mutations in the telomerase reverse transcriptase gene (TERT) promoter region are significant in bladder cancer, detectable in approximately 60%–70% of cases (Hurst et al., 2014) and strongly linked to carcinogenesis (Bell et al., 2016). This evidence concerns the gene TERT and urinary bladder carcinoma.